CME Presentations

Endometrial Cancer


Presentations


Speakers

  • Paul DiSilvestro, MD

    Paul DiSilvestro, MD

    Paul DiSilvestro, MD

    Professor, Department of Obstetrics and Gynecology

    Paul DiSilvestro, MD, is a professor of obstetrics and gynecology and director of the Division of Gynecologic Oncology at the Alpert School of Medicine at Brown University, and director of the Program in Women’s Oncology at Women and Infants Hospital (WIH) in Providence, Rhode Island. His research interests include clinical trials in gynecologic cancer, with special emphasis on national cooperative group clinical research. Dr DiSilvestro is co-chair of the Gynecologic Cancer Committee at NRG Oncology after serving in several other leadership roles there and is a newly appointed member of the Gynecologic Cancer Steering Committee of the National Cancer Institute. He has won numerous teaching awards and has served as a mentor to residents, fellows, and junior faculty throughout his career.

CME Information

Resolving Unmet Treatment and Quality-of-Life Needs of Patients with Recurrent Endometrial Cancer


PIM Logo PQH Logo

LEARNING OBJECTIVES

After completing this activity, the participant should be better able to:
  • Evaluate the relevance of histology and molecular testing to facilitate treatment decision-making
  • Assess the clinical-trial evidence of new and practice-changing therapies for the management of recurrent endometrial cancer
  • Evaluate strategies to monitor and evaluate treatment-emergent adverse events associated with current and emerging regimens
  • Facilitate discussions between patients and providers to mitigate and manage long-term quality of life
Jointly provided by Postgraduate Institute for Medicine and PlatformQ Health Education, LLC.

ACKNOWLEDGEMENT

This activity is supported by educational grants from Eisai Inc. and Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc.

TUITION

Complimentary

JointlyAccreditedProvider Logo

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DATE OF RELEASE/EXPIRATION

The enduring material will be available from December 5, 2020 to December 5, 2021.

TARGET AUDIENCE

The intended audiences for this activity are gynecologic and medical oncologists, obstetrician/gynecologists, nurse practitioners, physician assistants, and oncology nurses involved in the treatment and management of patients with endometrial cancer.

ESTIMATED TIME TO COMPLETE

This activity should take approximately 1 hour to complete.

METHOD OF PARTICIPATION

There are no fees to participate in this activity. To participate in the activity, go to www.OMedLive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

DISCLOSURE OF CONFLICTS OF INTEREST

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter Reported Financial Relationship
Paul A. DiSilvestro, MD
Professor, Department of Obstetrics and Gynecology
Director, Program in Women’s Oncology and Division of Gynecologic Oncology
Women and Infants Hospital of RI
Consulting Fee: AbbVie, GSK/Tesaro

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Planner Reported Financial Relationship
Tariqa Ackbarali
Medical Director
PlatformQ Health Education, LLC
None

The PIM planners and managers have nothing to disclose.

The following PlatformQ Health Education, LLC planner, Jaimee Harris-Gold, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable):

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION

Accreditation Support: Please contact the Postgraduate Institute for Medicine at inquiries@pimed.com.

Technical Support: For any technical issues or issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at Support@OMedLive.com.